{"id":"concerta-ag-formulation","safety":{"commonSideEffects":[{"rate":"10%","effect":"Insomnia"},{"rate":"10%","effect":"Headache"},{"rate":"5%","effect":"Nausea"},{"rate":"5%","effect":"Vomiting"},{"rate":"5%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Methylphenidate increases the levels of norepinephrine and dopamine in the brain by preventing their reuptake, which improves attention and impulse control.","oneSentence":"Methylphenidate acts as a norepinephrine-dopamine reuptake inhibitor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:28:06.271Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Attention Deficit Hyperactivity Disorder (ADHD)"}]},"trialDetails":[{"nctId":"NCT02730572","phase":"","title":"Concerta (Methylphenidate) -To-Generic Switch Study","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-09","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":1464},{"nctId":"NCT02704546","phase":"NA","title":"Methylphenidate (Ritalin®) Effect During Exposure to Exercise and Heat Stress in ADD/ADHD Treated Patients","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2016-04","conditions":"Methylphenidate","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Methylphenidate"],"phase":"phase_2","status":"active","brandName":"Concerta AG formulation","genericName":"Concerta AG formulation","companyName":"Janssen Research & Development, LLC","companyId":"janssen-research-development-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methylphenidate acts as a norepinephrine-dopamine reuptake inhibitor. Used for Attention Deficit Hyperactivity Disorder (ADHD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}